Faculty

David Cluck, PharmD is a Professor in the Department of Pharmacy Practice at East Tennessee State University Gatton College of Pharmacy. He joined the college after completing a specialty residency in infectious diseases at Wake Forest Baptist Medical Center. Dr. Cluck maintains a clinical pharmacy practice in infectious diseases at Johnson City Medical Center. He is an active member of ACCP, IDSA, and AAHIVM.

Education, Degree, & Post Graduate Training:

• Auburn University (2009),
• Louisiana State University Health Sciences Center (Pharmacy Practice Residency 2010)
• Wake Forest Baptist Health (Infectious Diseases Residency 2011)

Teaching specialty:

Infectious Diseases

Classes taught:

 PMCY 3112 & PMCY 3114

Research Interests:

Antimicrobial Stewardship, Antimicrobial resistance, HIV

Selected Publications:

Cluck D, Covert KL, Wagner JL, Chastain DB. A primer on Post-COVID-19 conditions and implications for clinical pharmacists. J Am Coll Clin Pharm. 2022;5(7):716-724.

Stover KR, Chahine E, Cluck D, Green S, Chastain DB et al. A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2019, Open Forum Infectious Diseases, Volume 7, Issue 10, October 2020.

Derrick C, Bookstaver PB, Lu ZK, Bland CM, King ST, Stover KR, Rumley K, MacVane SH, Swindler J, Kincaid S, Branan T, Cluck D, Britt B, Pillinger KE, Jones BM, Fleming V, DiMondi VP, Estrada S, Crane B, Odle B, Al-Hasan MN, Justo JA. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species. Antibiotics (Basel). 2020 May 14;9(5):254.

Blevins SR, Hester EK, Chastain DB, Cluck D. Doravirine – A Return of the NNRTI Class? Ann Pharmacother. 2020 Jan;54(1):64-74.

Brooks KM, Sherman EM, Egelund EF, Brotherton A, Durham S, Badowski M, Cluck D. Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come? Pharmacotherapy 2019;39(5):576–598.

Cluck D et. al. Bacterial contamination of an automated pharmacy robot used for intravenous medication preparation. Infect Control Hosp Epidemiol. 2012 May;33(5):517-20. Epub 2012 Mar 16.

Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, et al. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy. 2024 May;44(5):360-382. 

Cady EA, Dillon AJ, Bourland K, Rybakov I, Cluck DB, Veve MP. You'll have to call the attending: Impact of a longitudinal, "real-time" case-based infectious diseases elective on entrustable professional activities to enhance APPE readiness. Curr Pharm Teach Learn. 2024 Apr 26;16(8):102092. 

Barfield RK, Brown ML, Albrecht B, Barber KE, Bouchard J, Carr AL, Chahine EB, Cluck D, Covington EW, Deri CR, Durham SH, Faulkner-Fennell C, Freeman LK, Gauthier TP, Gibson GM, Green SB, Hobbs ALV, Jones BM, Jozefczyk CC, Marx AH, McGee EU, McKamey LJ, Musgrove R, Perez E, Slain D, Stover KR, Turner MS, White C, Bookstaver PB, Bland CM. A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022. Open Forum Infect Dis. 2024 Jan 4;11(3):ofad687. 

Organizational Involvement/Membership:

ASHP, ACCP, AAHIVM, IDSA